ABK Biomed Lands $1.25M in Funding
ABK Biomedical of Halifax aims to have its treatment for uterine fibroids ready to roll out in Canada within 18 months with the help of a $1.25 million fundraising round announced yesterday.
The company, which was developed by researchers at Dalhousie University, has received a $500,000 equity investment from a group of Atlantic Canadian angels, $250,000 in venture capital from Innovacorp and a $500,000 loan from the Atlantic Canada Opportunities Agency.
ABK Biomedical also announced that it has hired a chief executive, Pat O’Connor, a former executive with Boston Scientific, one of the